Layer‐by‐layer interleukin‐12 nanoparticles drive a safe and effective response in ovarian tumors

Ovarian cancer is especially deadly, challenging to treat, and has proven refractory to known immunotherapies. Cytokine therapy is an attractive strategy to drive a proinflammatory immune response in immunologically cold tumors such as many high grade ovarian cancers; however, this strategy has been...

Descripción completa

Detalles Bibliográficos
Autores principales: Barberio, Antonio E., Smith, Sean G., Pires, Ivan S., Iyer, Sonia, Reinhardt, Ferenc, Melo, Mariane B., Suh, Heikyung, Weinberg, Robert A., Irvine, Darrell J., Hammond, Paula T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10013828/
https://www.ncbi.nlm.nih.gov/pubmed/36925719
http://dx.doi.org/10.1002/btm2.10453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10013828/
https://www.ncbi.nlm.nih.gov/pubmed/36925719
http://dx.doi.org/10.1002/btm2.10453

Ejemplares similares